Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings

将成瘾和传染病服务纳入农村地区的初级保健

基本信息

  • 批准号:
    10670120
  • 负责人:
  • 金额:
    $ 115.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-01 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

Abstract The US strategy to End the HIV Epidemic calls for expanded prevention of new infections and more effective responses to HIV outbreaks. These outbreaks often occur in counties and states that share a disproportional burden of HIV, but the co-occurring and syndemic nature with opioid use disorder (OUD) leaves hundreds of additional counties and regions highly susceptible to new HIV (and HCV) outbreaks. West Virginia (WV) is one such mostly rural setting with an explosive opioid epidemic manifest by the highest per capita rate of overdoses and 5 counties with recent HIV outbreaks. Evidence-based practices to prevent and control HIV in clinical settings include medications for OUD (MOUD), ART treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP). Treatment with these medications, however, first requires screening and evaluation, followed by treatment (SET). Adoption of SET processes may in turn translate to better health outcomes if adequately facilitated. Most rural settings are poorly equipped to provide specialty HIV/HCV/OUD services – an important lesson from Scott County, Indiana. Yet rural settings rely mostly on primary care clinics (PCC) with inadequate expertise to provide these services. To overcome adoption barriers of SET processes for HIV/HCV/OUD, effective facilitation is key and the NIATx treatment improvement strategy combined with ongoing clinical education and support provided by Project ECHO has the potential to increase adoption to integrate specialty HIV/HCV/OUD services into PCCs. Using the i-PARiHS implementation framework, we propose to address this unmet need by first identifying barriers to adoption and scale-up of HIV/HCV/OUD services. Then we will facilitate practice transformation by integrating clinical prompts in the electronic health record (EHR) to screen for HIV/HCV/OUD, followed by treatment prompts. Treatment will be supported by Project ECHO that provides ongoing clinical support to inspire confidence in treatment, alongside a clinical dashboard embedded within the EHR as part of the quality performance improvement activities to sustain integrating HIV/HCV/OUD services into PCCs. We then propose to conduct a stepped wedge, Type 3, hybrid implementation trial to assess the extent to which clinicians adopt and sustain SET processes to integrate care at 20 PCCs that is facilitated by rapid cycle change projects using NIATx. Adoption of SET processes are the primary outcome and a composite quality health indicator (QHI) that combines QHIs for primary care, HIV, HCV and MOUD are secondary efficacy outcomes. Organizational and clinician factors, along with engagement in facilitation activities (NIATx, ECHO sessions) will be explored as potential mediators and moderators. Significance is high for the rural WV context where a volatile opioid epidemic has ignited HIV/HCV outbreaks. Innovation is high by integrating HIV/HCV/OUD services into PCCs using a framework and strategy we successfully used in urban international settings. Public health benefits are high given the lack of knowledge known about integrating services into rural PCCs. Feasibility is high based on the track record of an experienced team with interdisciplinary expertise and prior in WV.
摘要 美国结束艾滋病毒流行的战略呼吁扩大对新感染的预防并更加有效 应对艾滋病毒暴发。这些疫情通常发生在疫情不成比例的县和州。 艾滋病毒的负担,但阿片类药物使用障碍(OUD)的共生和共生性质留下了数百人 更多易受新的艾滋病毒(和丙型肝炎病毒)暴发影响的县和地区。西弗吉尼亚州就是其中之一。 这种主要是农村地区的阿片类药物爆炸性流行的环境,表现为人均过量服药率最高 以及最近艾滋病毒暴发的5个县。临床环境中预防和控制艾滋病毒的循证做法 包括药物治疗(Moud)、抗逆转录病毒治疗作为预防(TasP)和暴露前预防 (准备)。然而,使用这些药物治疗首先需要进行筛选和评估,然后 治疗(套装)。如果适当地采用既定的程序,反过来可能转化为更好的健康结果 提供便利。大多数农村地区缺乏提供专门的艾滋病毒/丙型肝炎病毒/艾滋病服务的能力--这是一个重要的 印第安纳州斯科特县的教训。然而,农村地区大多依赖初级保健诊所(PCC), 提供这些服务的专业知识。为了克服艾滋病毒/丙型肝炎/艾滋病既定程序的采用障碍, 有效的促进是关键,NIATx治疗改进策略与正在进行的临床相结合 由Project Echo提供的教育和支持有可能增加对整合专业的采用 向初级保健中心提供艾滋病毒/丙型肝炎/艾滋病服务。利用i-PARiHS实施框架,我们建议解决这一问题 首先确定采用和扩大艾滋病毒/丙型肝炎病毒/艾滋病服务的障碍,以满足未得到满足的需求。那么我们就会促成 通过将临床提示集成到电子健康记录(EHR)中以筛选 艾滋病毒/丙型肝炎病毒/OUD,然后是治疗提示。治疗将由Echo项目提供支持,该项目提供 持续的临床支持,以激发对治疗的信心,以及嵌入在 EHR作为质量业绩改进活动的一部分,以持续将艾滋病毒/丙型肝炎/艾滋病服务整合到 PCS。然后,我们建议进行阶梯式楔形、类型3、混合实施试验,以评估程度 临床医生采用并维持既定流程,在快速周期的推动下,在20个PCC中整合护理 使用NIATx更改项目。采用设定的流程是主要结果,也是一种综合质量 健康指标(QHI)结合了初级保健、艾滋病毒、丙型肝炎和穆德的QHI是次要效果 结果。组织和临床医生因素,以及参与促进活动(NIATx、ECHO 会议)将作为潜在的调解人和主持人进行探讨。对农村WV背景的意义很高 在那里,不稳定的阿片类药物流行引发了艾滋病毒/丙型肝炎的爆发。通过整合艾滋病毒/丙型肝炎病毒/OUD实现创新 利用我们在国际城市环境中成功使用的框架和战略,将服务引入方案控制中心。公众 由于缺乏将服务纳入农村初级保健服务的知识,健康福利很高。可行性 基于一支经验丰富的团队的记录,该团队具有跨学科的专业知识,并在西弗吉尼亚州拥有更高的经验。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FREDERICK LEWIS ALTICE其他文献

FREDERICK LEWIS ALTICE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FREDERICK LEWIS ALTICE', 18)}}的其他基金

Prison Interventions and HIV Prevention Collaboration
监狱干预和艾滋病毒预防合作
  • 批准号:
    10548569
  • 财政年份:
    2023
  • 资助金额:
    $ 115.52万
  • 项目类别:
Innovations in Implementing Decentralized HIV Services in Peru
秘鲁实施分散式艾滋病毒服务的创新
  • 批准号:
    10762842
  • 财政年份:
    2023
  • 资助金额:
    $ 115.52万
  • 项目类别:
Reducing Stigma in People Who Inject Drugs with HIV Using a Rapid Start Antiretroviral Therapy Intervention
使用快速启动抗逆转录病毒治疗干预措施减少艾滋病毒注射者的耻辱
  • 批准号:
    10756389
  • 财政年份:
    2023
  • 资助金额:
    $ 115.52万
  • 项目类别:
Georgian Implementation Science Fogarty Training Program (GIFT)
格鲁吉亚实施科学福格蒂培训计划 (GIFT)
  • 批准号:
    10688700
  • 财政年份:
    2023
  • 资助金额:
    $ 115.52万
  • 项目类别:
Expanding Medication Assisted Therapies in Central Asia
在中亚扩大药物辅助治疗
  • 批准号:
    10693856
  • 财政年份:
    2022
  • 资助金额:
    $ 115.52万
  • 项目类别:
Expanding Medication Assisted Therapies in Central Asia
在中亚扩大药物辅助治疗
  • 批准号:
    10403273
  • 财政年份:
    2022
  • 资助金额:
    $ 115.52万
  • 项目类别:
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings
将成瘾和传染病服务纳入农村地区的初级保健
  • 批准号:
    10311425
  • 财政年份:
    2021
  • 资助金额:
    $ 115.52万
  • 项目类别:
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings
将成瘾和传染病服务纳入农村地区的初级保健
  • 批准号:
    10453688
  • 财政年份:
    2021
  • 资助金额:
    $ 115.52万
  • 项目类别:
Malaysian Implementation Science Training (MIST) Program in HIV
马来西亚艾滋病毒实施科学培训(MIST)计划
  • 批准号:
    10358577
  • 财政年份:
    2020
  • 资助金额:
    $ 115.52万
  • 项目类别:
Modeling the impact and cost-effectiveness of opioid agonist treatments to reduce the negative consequences of incarceration on HIV and TB transmission in Eastern Europe and Central Asia
对阿片类激动剂治疗的影响和成本效益进行建模,以减少监禁对东欧和中亚艾滋病毒和结核病传播的负面影响
  • 批准号:
    10013670
  • 财政年份:
    2020
  • 资助金额:
    $ 115.52万
  • 项目类别:

相似海外基金

The European Hydrogen Academy (HyAcademy.EU)
欧洲氢学院 (HyAcademy.EU)
  • 批准号:
    10110448
  • 财政年份:
    2024
  • 资助金额:
    $ 115.52万
  • 项目类别:
    EU-Funded
REU Site: Summer Academy in Sustainable Manufacturing
REU 网站:可持续制造夏季学院
  • 批准号:
    2348993
  • 财政年份:
    2024
  • 资助金额:
    $ 115.52万
  • 项目类别:
    Standard Grant
GP-UP Ocean Research College Academy Engagement in Authentic Geoscience Learning Ecosystems (ORCA-EAGLE)
GP-UP 海洋研究学院学院参与真实的地球科学学习生态系统 (ORCA-EAGLE)
  • 批准号:
    2326962
  • 财政年份:
    2024
  • 资助金额:
    $ 115.52万
  • 项目类别:
    Standard Grant
HyAcademy.EU: The European Hydrogen Academy
HyAcademy.EU:欧洲氢学院
  • 批准号:
    10101978
  • 财政年份:
    2024
  • 资助金额:
    $ 115.52万
  • 项目类别:
    EU-Funded
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 115.52万
  • 项目类别:
    Operating Grants
Conference: Cyberinfrastructure Leadership Academy: Team Science and Grand Challenges
会议:网络基础设施领导学院:团队科学和重大挑战
  • 批准号:
    2414440
  • 财政年份:
    2024
  • 资助金额:
    $ 115.52万
  • 项目类别:
    Standard Grant
Travel: NSF Student Travel Grant for 2024 Academy of Management Annual Meeting (AOM)
旅行:2024 年管理学院年会 (AOM) 的 NSF 学生旅行补助金
  • 批准号:
    2420866
  • 财政年份:
    2024
  • 资助金额:
    $ 115.52万
  • 项目类别:
    Standard Grant
Semiconductor Higher Technical Skills Academy Wales: Recruitment, Retention & Upskilling
威尔士半导体高等技术技能学院:招聘、保留
  • 批准号:
    10076049
  • 财政年份:
    2023
  • 资助金额:
    $ 115.52万
  • 项目类别:
    Collaborative R&D
Simulation Academy at Yale: Youth Entering Science (SAY-YES!)
耶鲁大学模拟学院:青年进入科学(说是!)
  • 批准号:
    10663646
  • 财政年份:
    2023
  • 资助金额:
    $ 115.52万
  • 项目类别:
Collaborative Research: GP-GO: Climate Leaders Academy: a professional development opportunity in the geosciences
合作研究:GP-GO:气候领袖学院:地球科学领域的专业发展机会
  • 批准号:
    2232215
  • 财政年份:
    2023
  • 资助金额:
    $ 115.52万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了